With Easter Monday (1 April 2024) occurring in the first five days of the FP34C submission window, pharmacy owners will have an extra day, until the end of 6 April 2024, to submit their March FP34Cs using the Manage Your Service (MYS) portal and to dispatch their prescription bundle to the relevant pricing division at the
Read moreA social media event highlighting the great work of pharmacy teams is taking place on Thursday 28th March 2024, and Community Pharmacy England will be supporting it. As the last working day before the Easter holidays, Thursday will be the busiest day of the year for many pharmacists, offering a key moment to shine a
Read moreGP Connect: Update Record is currently being rolled out within prescribing systems, with pharmacy IT systems starting rollouts as they become ready. As systems suppliers align with this, there will be lesser need to send consultation details from pharmacy to GP practice via NHSmail, for those service IT modules which have the feature added. Pharmacy
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Isosorbide mononitrate (Monomil® XL) 60mg modified-release tablets. MSN/2024/034 Tier 2 – medium impact Date of issue: 26th March 2024 Isosorbide mononitrate (Monomil® XL) 60mg modified-release tablets are out of stock until the end of June 2024 Chemydur® 60XL, Isotard® 60XL, Relosorb®
Read moreIn response to a significant ongoing disruption to the supply of Monomil® XL 60mg tablets, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 26th March 2024, SSP059 provides that for every Monomil® XL 60mg tablets originally prescribed one alternative brand of a Isosorbide mononitrate 60mg modified-release tablets
Read moreThe Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 April 2024. Part VIIIA – Basic prices of drugs Contractors should note changes made to: Basic Price of Drugs covered by Part II Clause 8A
Read moreFrom 1 April 2024, the pack size listings of Xarelto® (Rivaroxaban) 1mg/ml granules for oral suspension will be updated. This follows the identification by Community Pharmacy England of a discrepancy in the pack size listings for Xarelto® (Rivaroxaban) 1mg/ml granules for oral suspension. Currently, the pack sizes listed in the Drug Tariff and the NHS
Read moreCommunity Pharmacy England is looking for a Dispensing and Supply Pharmacist to join our Pharmacy Funding Team. If you’re passionate about community pharmacy and eager to support pharmacy owners through this specialised role, we’re keen to hear from you. The Dispensing and Supply Pharmacist will be responsible for providing professional expertise on policy areas concerning
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices MSN/2024/032 Tier 2 – medium impact Date of issue: 21st March 2024 Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices are being discontinued
Read moreClass 4 Medicines Defect Information: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited) Drug alert number: EL (24)A/10 Date issued: 21 March 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited) Company name: Fresenius Kabi
Read more
